Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients
Clinical trial NCT04657315 · COMPLETED
Trial details
- NCT number
- NCT04657315
- Sponsor
- CHA University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-24
- Primary completion
- 2022-12-22
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.